A
Aifei Intelligent Pharma
AIPher is an AI-native drug development company .
Funding
Every round, secondary, debt facility or acquisition involving Aifei Intelligent Pharma that AI Lounge tracks, newest first. Latest: Angel (seed) on Sep 3, 2026.
Timeline · 1
Round
Angel (seed) · $14.9M (CNY 100.0M)
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in